Surgical Treatment of Atrial Fibrillation
Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, mortality, and reduced quality of life. Although catheter ablation is the most widely used rhythm control strategy, its efficacy is limited in patients with non-paroxysmal atrial fibrillation and large left atria. To address this therapeutic gap, surgical approaches, including minimally invasive ablation, hybrid epicardial-endocardial strategies, and left atrial appendage exclusion, have continued to evolve. In this review, we focus on recent evidence to guide clinical decision-making on patient selection, advances in minimally invasive surgical and hybrid techniques, left atrial appendage exclusion, and postoperative anticoagulation management. Minimally invasive standalone Cox-Maze IV procedure and hybrid epicardial-endocardial ablation have demonstrated superior long-term freedom from atrial tachyarrhythmias compared with thoracoscopic epicardial surgical ablation or catheter ablation alone. Five-year arrhythmia-free survival has approached 85% to 95% in experienced centers after the Cox-Maze IV procedure and approximately 60% to 70% after hybrid ablation, compared with 35% to 45% after thoracoscopic epicardial ablation and 30% to 35% after single catheter ablation alone. Surgical left atrial appendage exclusion performed at the time of ablation may further reduce thromboembolic risk, although the optimal strategy for postprocedural anticoagulation remains uncertain. Careful patient selection remains essential, with atrial fibrillation type, duration, left atrial size, and previous treatment failure known to be key predictors of procedural success. As surgical techniques and supporting evidence continue to grow, standalone surgical ablation may assume a more important role in the contemporary management of atrial fibrillation, particularly for patients with advanced disease who are unlikely to achieve durable rhythm control with catheter ablation alone.
Authors
- Ali J. Khiabani (ORCID: https://orcid.org/0000-0002-7814-1466)
- Ralph J. Damiano (ORCID: https://orcid.org/0000-0002-6361-6107)
Institutions
- Barnes-Jewish Hospital (US)
- Washington University in St. Louis (US)
Publication Details
- Journal
- Circulation
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1161/circulationaha.126.083715
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00